Literature DB >> 1941499

Species difference of site-selective glucuronidation of morphine.

C K Kuo1, N Hanioka, Y Hoshikawa, K Oguri, H Yoshimura.   

Abstract

Species difference in glucuronidation of morphine was studied using mice, rats, guinea pigs and rabbits in vivo and in vitro. Morphine-3-glucuronide (M-3-G) and morphine-6-glucuronide (M-6-G) were determined by high-performance liquid chromatography. M-3-G was the major urinary metabolite of morphine in all these animal species. However, a remarkable species difference was observed in the urinary excretion of the M-6-G. Excretion ratios of the M-3-G to M-6-G were approximately 4:1 and 50:1 in guinea pigs and rabbits, respectively. The urinary excretion of M-6-G in mice and rats was too small to be determined. On the other hand, the ratios of uridine diphosphate-glucuronyltransferase (UDPGT) activities toward 3- and 6-hydroxyl groups of morphine in liver microsomes of mice, rats, guinea pigs and rabbits were approximately 300:1, 90:1, 4:1 and 40:1, respectively. Ratios of two morphine UDPGT activities in the liver microsomes of guinea pigs and rabbits, thus, reflected those of urinary excretion of morphine glucuronides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941499     DOI: 10.1248/bpb1978.14.187

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  28 in total

1.  Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.

Authors:  R W Milne; R H Jensen; C Larsen; A M Evans; R L Nation
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Impact of ageing on the antinociceptive effect of reference analgesics in the Lou/c rat.

Authors:  Didier Jourdan; Gisèle Pickering; Fabien Marchand; Jean-Michel Gaulier; Josette Alliot; Alain Eschalier
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 3.  Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

Authors:  B Afsharimani; C W Doornebal; P J Cabot; M W Hollmann; M-O Parat
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

4.  Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms.

Authors:  Lindsay B Hough; Julia W Nalwalk; Xinxin Ding; Nico Scheer
Journal:  Drug Metab Dispos       Date:  2015-06-24       Impact factor: 3.922

5.  Paradoxical pain.

Authors:  C L Davis; R Turner
Journal:  BMJ       Date:  1993-03-20

6.  Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.

Authors:  Noam Zelcer; Koen van de Wetering; Michel Hillebrand; Elise Sarton; Annemieke Kuil; Peter R Wielinga; Thomas Tephly; Albert Dahan; Jos H Beijnen; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-10       Impact factor: 11.205

7.  Morphine blood-brain barrier transport is influenced by probenecid co-administration.

Authors:  Karin Tunblad; E Niclas Jonsson; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

8.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

9.  Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling.

Authors:  Jennie L Conroy; Cheng Fang; Jun Gu; Scott O Zeitlin; Weizhu Yang; Jun Yang; Melissa A VanAlstine; Julia W Nalwalk; Phillip J Albrecht; Joseph E Mazurkiewicz; Abigail Snyder-Keller; Zhixing Shan; Shao-Zhong Zhang; Mark P Wentland; Melissa Behr; Brian I Knapp; Jean M Bidlack; Obbe P Zuiderveld; Rob Leurs; Xinxin Ding; Lindsay B Hough
Journal:  Nat Neurosci       Date:  2010-02-07       Impact factor: 24.884

10.  Direct nose-to-brain transfer of morphine after nasal administration to rats.

Authors:  Ulrika Espefält Westin; Emma Boström; Johan Gråsjö; Margareta Hammarlund-Udenaes; Erik Björk
Journal:  Pharm Res       Date:  2006-02-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.